Who Paid My Doc
AMPLATZER PFO Occluder Post Approval Study
ClinicalTrials.gov NCT03309332
Research payments
$899,985
Through program year 2020, $899,985 in research payments was reported against AMPLATZER PFO Occluder Post Approval Study, across 510 payments, paid by Abbott Laboratories.
- Paid by
- Abbott Laboratories
- ClinicalTrials.gov
- NCT03309332
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $899,985 | 510 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Wilson Ginete Duluth, MN Named on 19 payments
- Nilesh Goswami Springfield, IL Named on 18 payments
- Tanvir Bajwa Milwaukee, WI Named on 15 payments
- Matthew Wiisanen Chattanooga, TN Named on 14 payments
- Tomasz Stys Sioux Falls, SD Named on 13 payments
- Ahmad Munir Flint, MI Named on 12 payments
- Clifford Kavinsky Chicago, IL Named on 12 payments
- Vaikom Mahadevan San Francisco, CA Named on 12 payments
- Mark Kozak Hershey, PA Named on 11 payments
- Gaurav Dhar Lansing, MI Named on 11 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.